Skip to main content
About us
About us
Governance
IDDO Team
Our partners
Contact us
Jobs
Data
Explore data
Accessing data
Data Access Guidelines
Contributing data
Why share your data
Frequently Asked Questions
IDDO legal and regulatory documentation
Science
Science
WWARN malaria
COVID-19
Ebola
Visceral leishmaniasis
Medicine Quality
Antimicrobial Resistance
Schistosomiasis & STHs
Chagas Disease
Febrile illness
Scrub typhus
Trachoma
Other diseases
Equity
Our approach
IDDO Blogs
News
Publications
About us
About us
Governance
IDDO Team
Our partners
Contact us
Jobs
Data
Explore data
Accessing data
Data Access Guidelines
Contributing data
Why share your data
Frequently Asked Questions
IDDO legal and regulatory documentation
Science
Science
WWARN malaria
COVID-19
Ebola
Visceral leishmaniasis
Medicine Quality
Antimicrobial Resistance
Schistosomiasis & STHs
Chagas Disease
Febrile illness
Scrub typhus
Trachoma
Other diseases
Equity
Our approach
IDDO Blogs
News
Publications
LOGIN
Please note that the content has been automatically translated from English original. There may on occasion be slight inaccuracies in this automatic translation
Resources for researchers
Downloadable resources for researchers
i
Photo: Arne Hoel, World Bank
DP Dose Impact Study Group presentation
Document
Pharmacology PK/PD Day 7 lumefantrine Statistical Analysis Plan
Document
PCE CSV file template
Document
Study group summary of risk factors affecting dosing efficacy for ASTMH 2013
Document
PCE Terms of Use
Document
RSA training workshop agenda
Document
WWARN agenda of activities ASTMH 2013
Document
PCE Example Automated Report
Document
Extracted data from P. vivax antimalarial efficacy study sites
Document
PCE Methodology
Document
Pagination
First page
« First
Previous page
‹‹
Page
1
Page
2
Page
3
Page
4
Current page
5
Page
6
Page
7
Page
8
Page
9
…
Next page
››
Last page
Last »
Research Agenda Development Process
View process
